Institutional members access full text with Ovid®

Share this article on:

The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?

Nanni, Cristinaa; Schiavina, Riccardob; Rubello, Domenicoc; Ambrosini, Valentinaa; Brunocilla, Eugeniob; Martorana, Giuseppeb; Fanti, Stefanoa

doi: 10.1097/MNM.0b013e3283636eaf
Editorial

Departments of aNuclear Medicine

bRadiology and Urology, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola-Malpighi, Bologna

cDepartment of Imaging, Nuclear Medicine, Radiology, NeuroRadiology, Medical Physics, Santa Maria della Misericordia Hospital, Rovigo, Italy

Correspondence to Domenico Rubello, MD, Department of Imaging, Nuclear Medicine, Radiology, NeuroRadiology, Medical Physics, Santa Maria della Misericordia Hospital, Rovigo 54100, Italy Tel: +39 0425 39 4428; fax: +39 0425 39 4434; e-mail: domenico.rubello@libero.it

Received February 27, 2013

Accepted May 20, 2013

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins